Giacomo Sgalla

21PUBLICATIONS
15CO-AUTHORS
AllergyInnate immunityMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Apr 10, 2026
Multidisciplinary management of interstitial lung disease in autoimmune rheumatic diseases: an Italian Delphi consensus.

Marco Sebastiani, Elena Bargagli, Stefania Cerri

|Jul 29, 2025
A Simple Ratio in a Complex Disease: Exploring the Neutrophil-to-Lymphocyte Ratio in Idiopathic Pulmonary Fibrosis.

Giorgio Monteleone, Luca Passantino, Jacopo Simonetti

|Jan 24, 2023
BI 1015550: an investigational phosphodiesterase 4B (PDE4B) inhibitor for lung function decline in idiopathic pulmonary fibrosis (IPF).

Giacomo Sgalla, Jacopo Simonetti, Stefania Cortese

|Dec 15, 2021
Advances with pharmacotherapy for the treatment of interstitial lung disease.

Alessia Comes, Giacomo Sgalla, Alessandro Perrotta

|Nov 29, 2021
COVID-related fibrosis: insights into potential drug targets.

Giacomo Sgalla, Alessia Comes, Marialessia Lerede

|May 17, 2021
Emerging drugs for the treatment of idiopathic pulmonary fibrosis: 2020 phase II clinical trials.

Giacomo Sgalla, Marialessia Lerede, Luca Richeldi

Pageof 4

Frequent Collaborators

3 joint publications

Luca Richeldi

3 joint publications

Alessia Comes

1 joint publications

Nicoletta Fusco

1 joint publications

Luca Passantino